BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 9665815)

  • 21. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells.
    Yokomuro S; Tsuji H; Lunz JG; Sakamoto T; Ezure T; Murase N; Demetris AJ
    Hepatology; 2000 Jul; 32(1):26-35. PubMed ID: 10869285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.
    Mou S; Wang Q; Shi B; Gu L; Ni Z
    Kaohsiung J Med Sci; 2009 Nov; 25(11):577-87. PubMed ID: 19858036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions.
    Matsumoto K; Nakamura T
    Crit Rev Oncog; 1992; 3(1-2):27-54. PubMed ID: 1312869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-alpha in rat liver epithelial cells.
    Presnell SC; Stolz DB; Mars WM; Jo M; Michalopoulos GK; Strom SC
    Mol Carcinog; 1997 Apr; 18(4):244-55. PubMed ID: 9142219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways.
    Warn R; Harvey P; Warn A; Foley-Comer A; Heldin P; Versnel M; Arakaki N; Daikuhara Y; Laurent GJ; Herrick SE; Mutsaers SE
    Exp Cell Res; 2001 Jul; 267(2):258-66. PubMed ID: 11426944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
    Kawaguchi Y; Harigai M; Hara M; Fukasawa C; Takagi K; Tanaka M; Tanaka E; Nishimagi E; Kamatani N
    J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure.
    Liu Y; Tolbert EM; Lin L; Thursby MA; Sun AM; Nakamura T; Dworkin LD
    Kidney Int; 1999 Feb; 55(2):442-53. PubMed ID: 9987069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
    Li Y; Chen N; Yu HJ; Dong XP; Huang QH
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
    Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
    Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte growth factor induces tubulogenesis of primary renal proximal tubular epithelial cells.
    Bowes RC; Lightfoot RT; Van De Water B; Stevens JL
    J Cell Physiol; 1999 Jul; 180(1):81-90. PubMed ID: 10362020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat.
    Hu Z; Evarts RP; Fujio K; Marsden ER; Thorgeirsson SS
    Am J Pathol; 1993 Jun; 142(6):1823-30. PubMed ID: 8506951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea.
    Li Q; Weng J; Mohan RR; Bennett GL; Schwall R; Wang ZF; Tabor K; Kim J; Hargrave S; Cuevas KH; Wilson SE
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):727-39. PubMed ID: 8603858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and action of hepatocyte growth factor in bovine endometrial stromal and epithelial cells in vitro.
    Murakami S; Miyamoto Y; Fujiwara C; Takeuchi S; Takahashi S; Okuda K
    Mol Reprod Dev; 2001 Dec; 60(4):472-80. PubMed ID: 11746958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
    Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
    Colombo ES; Menicucci G; McGuire PG; Das A
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.
    Christensen JG; Burrows J; Salgia R
    Cancer Lett; 2005 Jul; 225(1):1-26. PubMed ID: 15922853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity.
    Liang H; O'Reilly S; Liu Y; Abounader R; Laterra J; Maher VM; McCormick JJ
    Int J Oncol; 2004 May; 24(5):1057-67. PubMed ID: 15067326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibronectin fibrils and growth factors stimulate anchorage-independent growth of a murine mammary carcinoma.
    Saulnier R; Bhardwaj B; Klassen J; Leopold D; Rahimi N; Tremblay E; Mosher D; Elliott B
    Exp Cell Res; 1996 Feb; 222(2):360-9. PubMed ID: 8598224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
    Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M
    Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.